Peter Feinberg - 13 Sep 2021 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
Issuer symbol
IMRX
Transactions as of
13 Sep 2021
Net transactions value
+$131,114
Form type
4
Filing time
15 Sep 2021, 17:58:33 UTC
Previous filing
04 Aug 2021
Next filing
21 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $123,697 +5,750 +1.5% $21.51 392,242 13 Sep 2021 General Partner of PF Associates L.P. F1
transaction IMRX Class A Common Stock Purchase $7,416 +349 $21.25 349 13 Sep 2021 Direct F2
holding IMRX Class A Common Stock 476,615 13 Sep 2021 General Partner of PEF LLC.
holding IMRX Class A Common Stock 115,441 13 Sep 2021 General Partner of S4K Investments LLC.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.08 to $22.00. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.
F2 This transaction was executed in multiple trades through a broker-dealer at a price of $21.25. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.